Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NENT Group’s Danish hit original series ‘Face to Face’ set for second season

· Trine Dyrholm and Christoffer Boe return as star and director of second season · Season one of ‘Face to Face’ set viewing record for a NENT Group original series when premiered in November · NENT Group to premiere at least 20 original productions every year Nordic Entertainment Group (NENT Group), the Nordic region’s leading streaming company, has commissioned a second season of its record breaking Danish original series ‘Face to Face’. The first season is the most watched NENT Group original series in November 2019. Season two of ‘Face to Face’ will premiere exclusively on

Norwegian energy distribution company chooses Rejlers for improved safety through digitalization

Rejlers has signed an agreement with Norwegian energy distribution company Lyse Elnett on the delivery of services aimed at increasing safety around the use of electricity through more efficient digitalization. The agreement means that Rejlers will carry out an annual supervision of approximately 3,500 residential and business premises.Rejlers is one of the biggest suppliers of local electrical inspections in Norway, so called DLE-services (Det Lokale Eltilsyn). The agreement with Lyse Elnett aims mainly to reduce the number of fires caused by electrical faults and provide guidance in the

Martti Nurminen starts as CFO of Basware

Basware Corporation, stock exchange release, December 2, 2019 at 9:45 am EETMartti Nurminen starts today, December 2, 2019 as Chief Financial Officer of Basware and a member of the Executive Team. As announced on June 28, 2019, Nurminen joins Basware from Solteq Plc, a publicly listed Nordic IT and software company, where he previously served as the CFO. Prior to that, Nurminen worked in various senior financial management roles such as the CFO of Affecto Plc and as Finance Director at Johnson Controls. "I am enthusiastic to start as the CFO of Basware today. I look forward to working

East Capital Property Fund to Pay Special Dividend after Completing EUR 200m Investment Programme

East Capital’s third real estate fund will pay a special dividend as it starts to make regular income distributions since completing its 200 million-euro investment programme. East Capital Baltic Property Fund III’s Board has recommended starting to make regular 3% dividend payments twice a year, supplemented by a one-off payment equivalent to a 4.5% return on the capital committed by investors to the fund established in 2015. This follows the purchase last week of “Lidostas Parks,” a fully leased logistic park near\ \Riga International Airport, for around 19 million euros. Madis

Climeon delivers new steam turbine solution to Viking Line

Climeon has developed a new steam turbine solution tailored for Viking Line’s new ship Viking Glory. The two steam turbines have now passed a Factory Acceptance Test with Viking Line and the certification body DNV-GL present. The steam turbines are part of the order placed by Viking Line in 2017 and will be delivered to Viking Glory over the upcoming months. In 2015, Viking Line became the first company in the world to install a Climeon Heat Power module to utilize the waste heat from the ship’s engines. When Viking Line began designing the new ship, Viking Glory, they were sure of their

Numsbing AB (publ) is a dividend company

The Board of Directors of Numisbing AB (publ) has set new reporting dates for quarterly reports during 2020 and the beginning of 2021. In addition, future dividend policy has been formulated for Numisbing AB (publ). The company will generate a positive cash flow after dividends have been paid. The dividend should be well balanced with regard to the objectives, scope and risk of the business. The company has been active since 2012 and has always generated profits. In principle, the company has doubled its sales each year and has been able to generate a dividend to the shareholders of 50

RhoVac ends the collaboration with Colpman Consulting Ltd

RhoVac AB ("RhoVac") announces today, December 2 2019, that the collaboration agreement with Colpman Consulting Ltd ("Colpman Ltd") has been terminated by mutual agreement, in the light of RhoVac's aim to secure an agreement with a partner after completion of the current clinical phase IIb study.The agreement that RhoVac signed with Colpman Ltd in March 2018 to find a development partner for RV001 has been formally terminated by mutual agreement. In the future, RhoVac’s CEO, Anders Månsson, will lead the company's business development efforts, which aim to secure an agreement with a partner

Multiconsult initiates share buyback in connection with employee share purchase programme

The number of shares acquired on 28. November did not meet the demand from the employee share purchase programme. Multiconsult has therefore decided to initiate a share buyback programme for approximately 352 000 shares in the market in connection with its employee share purchase programme.The buyback programme will be conducted in accordance with the authorisation provided by the ordinary general meeting to the board of directors on 25 April 2019. The buyback will be executed through a reverse Dutch auction at a price of maximum 64.00 NOK per share on Oslo Børs. The programme will be

Black Friday successfully executed

A strong stock composition supported by a high number of campaign buys were key to a successful Black Friday weekend on both revenue and margin. The expectations were met or exceeded in all areas of the business.“Well through a successful Black Friday weekend I am proud to be part of this team. In these hectic days the commitment, agility and cooperation were as strong as ever before. Each team member played their role in the execution of our high ambitions in this Super Bowl of retail”, says CEO at Boozt, Hermann Haraldsson. Most Black Friday orders were shipped by Saturday, while all

Fastpartner offers common shares of series D

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONG KONG, CANADA, NEW ZEELAND, JAPAN, SWITZERLAND, OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. ADDITIONAL RESTRICTIONS ARE APPLICABLE. PLEASE SEE IMPORTANT INFORMATION AT THE END OF THE ANNOUNCEMENT.Fastpartner AB (publ) (“Fastpartner”) intends to issue common shares of series D (“D-shares”) to the general public in Sweden and institutional investors in Sweden and abroad

Flexion Mobile adds new strong title to its growing portfolio

Expands existing partnership with Chinese publisherLONDON, 2nd of December, 2019 – Flexion Mobile Plc (Nasdaq: FLEXM), the Android games distribution company today announced that it is expanding the cooperation with an existing Chinese publisher by adding a newly released mid-tier game to its portfolio. The title was launched in Google Play in early September and is already performing very well. The beautifully crafted 3D game is based on the classic Japanese manga anime series from the 1980s that got known in the West after it became popular in France. According to Datamagic, the game

BioArctic and Eisai to present data on BAN2401 at the Clinical Trials on Alzheimer’s Disease conference

Stockholm, Sweden, December 2, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that presentations related to BAN2401 will be given at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) conference to be held December 4-7 in San Diego, California, USA. Data regarding amyloid levels at the beginning of the open label extension phase of the Phase 2b study (Study 201) in patients with early Alzheimer’s disease will be presented by Eisai. Professor Lars Lannfelt, Uppsala University and BioArctic, will present binding profiles of BAN2401 and aducanumab to different

Kamux to expand in Helsinki Metropolitan Area by acquiring the business of Autosilta

Kamux        Press Release   2 December 2019 at 9:00 Kamux to expand in Helsinki Metropolitan Area by acquiring the business of Autosilta Kamux will be expanding in Helsinki Metropolitan Area by acquiring the business of Autosilta. Kamux Suomi Oy, part of Kamux Corporation, has signed an agreement to acquire the business and assets of Autosilta from Jagro Oy. The agreement was signed on 2 December 2019. The price of the transaction will not be published. The completion of the transaction is subject to approval by competition authorities Autosilta is focusing on used car sales, and

Orexo appoints Dennis Urbaniak as Executive Vice President Digital Health

· Appointment strengthens Orexo’s competencies and resources within digital health · Orexo committed to finding innovative solutions to improve treatment of addiction Uppsala, Sweden – December 2, 2019. Orexo AB (publ), the fully integrated specialty pharmaceutical company with the aim of becoming a leader within treatment of addiction, today announces it has appointed Dennis Urbaniak as Executive Vice President (EVP) of Digital Health, effective today. Dennis will lead the establishment of Orexo’s global digital health business, initially through the development of two digital

Multiconsult has purchased own shares through a share buyback programme

On 29 November 2019, Multiconsult ASA ("Multiconsult") purchased 157 184 of its own shares at an average price of NOK 64.00 per share. The shares were purchased through a reverse Dutch auction and in accordance with the share buyback programme as announced 28 November 2018. As a result, the reverse Dutch auction is completed. After the transaction Multiconsult holds 157 184 of its own shares.The shares purchased under this programme are for Multiconsult's 2019 employee share purchase programme as approved by the ordinary general meeting on 25 April 2019. This information is subject to

Oncopeptides appoints Joseph Horvat as President North America

Stockholm – December 2, 2019 - Oncopeptides AB (Nasdaq Stockholm: ONCO) announced today that Joseph Horvat has been appointed as President North America and CEO of Oncopetides Inc. Joseph will serve on the Management Team of Oncopeptides and will start today.The appointment of Joseph Horvat as President North America represents a significant milestone in the preparations for a potential US launch of melflufen in late 2020. With more than 23 years of pharmaceutical and biotech industry experience, Joseph brings in-depth knowledge spanning multiple therapeutic areas, brands, and geographies.

Lundin Mining Announces Closing of Sale of Interest in Kokkola Cobalt Refinery

Toronto, December 2, 2019 (TSX: LUN; Nasdaq Stockholm: LUMI) Lundin Mining Corporation (“Lundin Mining” or the “Company”) is pleased to announce that Freeport Cobalt, the Company’s joint venture with Freeport-McMoRan Inc. has completed the sale of the cobalt refinery in Kokkola, Finland and related cobalt cathode precursor business to Umicore for total cash consideration of approximately $200 million, including net working capital of approximately $50 million at the time of close (the “Transaction”). Lundin Mining is entitled to receive 30 percent of proceeds of the Transaction. The joint

Double Bond Pharmaceutical is a distributor of Inofer in Russia and Belarus

Last year, Double Bond Pharmaceutical and Laboratoire XO signed a distribution agreement for Inofer in Sweden, Norway, Denmark and Finland. Now Double Bond Pharmaceutical has the distribution rights for Russia and Belarus as well. Inofer is an iron supplement consisting of ferrous succinate which is a chemical iron form known to be more readily absorbed into the body of people with impaired iron uptake. According to WHO, "iron deficiency is the most common and widespread nutritional disorder in the world". Inofer is registered in France. The results of DBP's clinical trial of Inofer showed

Hemfosa acquires properties in Finland at a value of approximately MSEK 600

Hemfosa has acquired two properties in Finland for an underlying property value of approximately MSEK 600 and a total rental value of about MSEK 70.The properties are located in Tampere and Oulu. Community services tenants represent 90 percent of the rental value and include public broadcasting company Ylesradio, Oulu University Hospital, Tampere University of Applied Sciences and the City of Tampere. Both properties are well situated with good transport connections. The property located in Uleåborg also includes a development right for premises to accommodate healthcare operations and

PT Bahana Sekuritas deploys Itiviti’s high and low-touch trading solution

Jakarta, December 2, 2019 – Itiviti, a leading technology and service provider to financial institutions worldwide, today announced that PT Bahana Sekuritas, a major player in the Indonesian capital market, has deployed Itiviti’s high and low-touch trading solution to enhance order management capabilities and better serve its regional clients.The Itiviti solution, which includes a highly automated OMS platform as well as a connectivity and risk management layer, enables PT Bahana Sekuritas’ equities sales traders to effectively manage multiple Care and DMA client orders via a single

Share buy-backs in Telia Company during week 48 2019

During the period November 25, 2019, until November 29, 2019, Telia Company AB (publ) (LEI code 213800FSR9RNDUOTXO25) has repurchased in total 2,756,522 own shares (ISIN: SE0000667925). The share buy-backs form part of the SEK 5 billion share buy-back program that Telia Company announced on April 16, 2019. The share buy-back program, which runs between April 16, 2019, and February 28, 2020, is being carried out in accordance with the Market Abuse Regulation (EU) No 596/2014 ("MAR") and the Commission Delegated Regulation (EU) No 2016/1052 (the "Safe Harbour Regulation").During the period

The Board of Directors evaluates the offer from Ograi

Searchlight Capital Partners together with Lothar Geilen, through Ograi BidCo AB, today announced a public offer to the shareholders of Opus Group AB (“Opus”) to sell all shares in Opus to Ograi BidCo AB at a price of SEK 7.75 in cash per share (the “Offer”).The acceptance period of the Offer is expected to commence on December 5, 2019 and to expire on January 9, 2020, subject to any extensions. The Board of Directors1 will now evaluate the Offer, obtain a fairness opinion, and announce its opinion regarding the Offer no later than two weeks before the end of the acceptance period. The

Promore Pharma’s rights issue completed

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, WITHIN OR INTO THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, AUSTRALIA, HONG KONG, NEW ZEALAND, SWITZERLAND OR SINGAPORE OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION OR DISTRIBUTION WOULD BE CONTRAVENING TO ANY APPLICABLE RULES.Promore Pharma AB (publ) (”Promore Pharma” or the ”Company”) today announces that the new share issue with preferential rights for existing shareholders has been completed (the “Rights Issue”). The Rights Issue was subscribed to 80 percent, providing Promore Pharma with gross proceeds of

There are no items matching the current filter
There are no more items matching the current filter
Back to top